Thus, Gdpd3-mediated lysophospholipid metabolism regulates CML stem cell quiescence by suppressing the Akt–mTORC1 pathway and promoting nuclear Foxo3a localization. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.